购物车
全部删除
您的购物车当前为空
SHOC2–RAS PPI-IN-1 (compound 6) 是一种非共价竞争性抑制剂,专门抑制SHOC2和RAS蛋白的相互作用。此化合物对NRASQ61R的IC50为0.048 μM,KD为0.065 μM。其通过抑制SMP磷酸酶复合体,提升CRAFS259磷酸化水平,从而阻断MAPK信号通路(例如降低pMEK、pERK水平),并引发肿瘤细胞的周期阻滞和凋亡 (apoptosis)。SHOC2–RAS PPI-IN-1 可用于研究NRASQ61R突变的黑色素瘤和结直肠癌等恶性肿瘤的靶向治疗。
SHOC2–RAS PPI-IN-1 (compound 6) 是一种非共价竞争性抑制剂,专门抑制SHOC2和RAS蛋白的相互作用。此化合物对NRASQ61R的IC50为0.048 μM,KD为0.065 μM。其通过抑制SMP磷酸酶复合体,提升CRAFS259磷酸化水平,从而阻断MAPK信号通路(例如降低pMEK、pERK水平),并引发肿瘤细胞的周期阻滞和凋亡 (apoptosis)。SHOC2–RAS PPI-IN-1 可用于研究NRASQ61R突变的黑色素瘤和结直肠癌等恶性肿瘤的靶向治疗。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
SHOC2–RAS PPI-IN-1 相关产品
| 产品描述 | SHOC2–RAS PPI-IN-1 (compound 6) is a non-covalent competitive inhibitor that targets the interaction between SHOC2 and RAS proteins. It exhibits an IC50 of 0.048 μM and a KD of 0.065 μM against NRASQ61R. This compound inhibits SMP phosphatase-complex activity, increasing CRAFS259 phosphorylation levels and thus blocking the MAPK signaling pathway (by reducing pMEK and pERK levels). It induces cell cycle arrest and apoptosis in tumor cells. SHOC2–RAS PPI-IN-1 is used in targeting studies for malignancies, such as NRASQ61R-mutant melanoma and colorectal cancer. |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容